Related Experiment Video
Updated: May 26, 2026
07:29
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Inflammatory markers in hyperlipidemia: from experimental models to clinical practice
Gerasimos Siasos1, Dimitris Tousoulis, Evangelos Oikonomou
1Department of Biological Chemistry, University of Athens Medical School, Athens, Greece. gsiasos@med.uoa.gr
Current Pharmaceutical Design
|December 30, 2011
Summary
Inflammation significantly contributes to cardiovascular diseases and atherosclerosis, particularly when combined with lipid abnormalities. Further research is needed to effectively treat patients with both hyperlipidemia and inflammation.
Area of Science:
- Cardiovascular Science
- Immunology
- Metabolic Disorders
Background:
- Systemic inflammation and immune responses are integral to atherogenesis.
- Atherosclerosis development is strongly linked to chronic low-grade inflammation and lipid abnormalities.
- Research investigates the connection between hyperlipidemia and inflammatory status.
Purpose of the Study:
- To explore the association between hyperlipidemia and inflammatory markers.
- To review existing experimental and clinical data on this relationship.
- To identify gaps in clinical treatment strategies for patients with combined conditions.
Main Methods:
- Review of experimental and clinical studies.
- Analysis of associations between lipid levels and various inflammatory markers.
- Evaluation of current treatment approaches for hyperlipidemia.
Main Results:
- Numerous inflammatory markers (e.g., C-reactive protein, tumor necrosis factor-alpha, interleukin-6) are linked to lipid levels.
- Cholesterol-lowering treatments offer benefits but have limited clinical data for combined hyperlipidemia and inflammation.
- There is a need for more clinical trials focused on this patient group.
Conclusions:
- Inflammation is a key factor in cardiovascular disease development alongside lipid abnormalities.
- Current treatments for hyperlipidemia show benefits, but specific strategies for managing associated inflammation are lacking.
- Further clinical research is essential to develop effective therapeutic approaches for patients with both hyperlipidemia and impaired inflammatory status.
Related Concept Videos
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
01:38Inflammation
Overview
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...